Successful Joint Patient Education Event

The Neuroendocrine Life Alliance (NLA) 2026 Patient Summit held in Sheffield, UK on Saturday 6th June, proved a resounding success, delivering a high-quality, patient‑focused event that informed, connected and inspired attendees. The NLA is a collaboration between Neuroendocrine Cancer UK (NCUK) and the Association for Multiple Endocrine Neoplasia Disorders (AMEND). An impressive 97% rated the summit positively, with all participants keen to attend future events. Attendees gained valuable insights into treatments and research, boosting confidence and hope for the future. The event also reduced isolation by fostering strong peer connections within the community. Expert speakers praised its organisation and impact, highlighting high engagement and demand for more sessions. Overall, the summit set a strong foundation for future patient education and support initiatives by the NLA.
.

CLICK HERE TO READ THE FULL IMPACT REPORT